Science and Industry Research Act 1949

Statutory corporate entity. Section 8 establishes the Organisation as a body corporate with perpetual succession, a seal and powers to acquire and dispose of property and to sue and be sued. The Act integrates the Organisation into the corporate Commonwealth governance regime by cross‑reference to the Public Governance, Performance and Accountability Act 2013 (note to s 8(2)), so the Organisation operates both under this statute’s bespoke provisions and the generic PGPA framework for corporate Commonwealth entities.

Functions and prioritisation. Section 9 lists primary and secondary functions. Primary functions (s 9(2)(a)) are to carry out scientific research for specified purposes and to encourage or facilitate application or utilisation of research results. Secondary functions include services, facilities, liaison with other countries, training, awards and dissemination of scientific and technical information (s 9(1)(ba), (bb), (c)-(j)). The list expressly includes contributing to giving effect to Australia’s obligations under the Paris Agreement (s 9(1)(a)(iiia)), and allows the Minister to determine other purposes (s 9(1)(a)(iv)). The Act codifies a hierarchy: primary functions are to be treated as primary and other functions as secondary (s 9(2)(a)-(b)).

Transactional and commercial powers. Section 9AA grants broad powers necessary or convenient to perform functions, with specific inclusions: contracting third parties to undertake research or work (s 9AA(a)); forming or joining partnerships or companies (s 9AA(b)); licensing discoveries or inventions on terms, including fees and royalties as the Chief Executive determines (s 9AA(c)); paying bonuses to officers or others for discoveries, with Board approval (s 9AA(d)); and charging fees and conditions for services and facilities at the Chief Executive’s determination (s 9AA(e)). Those powers create explicit authority for revenue‑generating activity and commercial participation subject to internal decision‑making processes.

Governance architecture. The Board exists to ensure proper and efficient performance, determine policy, give directions to the Chief Executive and exercise such other functions as conferred by the Act (s 12). Part‑time members (7-9 members in addition to the Chief Executive) are appointed by the Governor‑General (s 14A). The Chief Executive is appointed by the Board, holds office full time for up to 5 years (s 10B(1)), conducts affairs subject to the Board’s policies and directions (s 10A(2)-(3)), and must disclose pecuniary interests in writing to the Board (s 10F).

Ministerial oversight and Finance Minister control. The Minister may give written directions and guidelines to the Board and those must be complied with (s 13(1)). The Finance Minister can direct amounts and timing for appropriated moneys payable to the Organisation (s 46(2)). The Board must consult the Minister before appointing or terminating the Chief Executive (s 10B(2), s 10E(4)), and the annual report must disclose Ministerial determinations and directions (s 51(c)-(d)).

Intellectual property and staff incentives. The Act declares that inventions by officers in the course of official duties are the property of the Organisation and makes unauthorised patent applications by officers a breach unless written consent of the Chief Executive is provided (s 54(1)-(2)). Separately, the Organisation may pay bonuses to officers for discoveries or inventions (s 9AA(d)), but such bonuses require Chief Executive determination and Board approval.

Administrative and operational instruments. The Chief Executive may delegate powers with Board approval (s 10J(1)-(2)); the Board may delegate its powers by resolution to eligible persons or committees (s 22A). Advisory committees and a Consultative Council exist to provide advice to the Board and represent officers respectively (ss 24, 56). Staff are appointed by the Chief Executive and their terms and conditions (other than statutory matters) are determined by the Chief Executive (s 32).

Finance and reporting. The Organisation receives appropriated funds (s 46(1)), is required to apply moneys only for specified organisational costs and remuneration (s 48(1)), may invest surplus funds under the PGPA Act (s 48(2)), and must include specified policy statements and ministerial determinations in its annual report (s 51). The Organisation is exempt from taxation (s 53).

Regulatory canvas. The Governor‑General may make regulations not inconsistent with the Act to prescribe matters required or convenient to give effect to the legislation (s 58). In multiple places the Act refers to determinations by the Remuneration Tribunal for salaries and allowances of members and the Chief Executive (ss 17, 19, 10H), tying remuneration processes to external statutory instruments.

Parliament and taxpayers. The Act channels public funding to the Organisation by appropriation (s 46(1)), so taxpayers ultimately finance the Organisation’s baseline operations. The Finance Minister also controls timing and amounts of those appropriations (s 46(2)), which affects cashflow and budget execution.

The Organisation and its officers. The Organisation itself, created at s 8, is the primary legal subject. Officers appointed under s 32 are governed by organisational controls: inventions made in the course of official duties are the Organisation’s property (s 54(1)), and officers are restricted from applying for patents without the Chief Executive’s written consent (s 54(2)). Officers’ remuneration and terms (other than statutory items) are set by the Chief Executive (s 32(2)), and bonuses for discoveries may be payable by the Organisation subject to Chief Executive determination and Board approval (s 9AA(d)).

Board members and Chief Executive. Part‑time Board members (including Chairperson and Deputy Chairperson) are appointed by the Governor‑General (s 14A(3)-(4)) and are paid remuneration determined by the Remuneration Tribunal (ss 17, 19). The Chief Executive is appointed by the Board (s 10B(1)), holds full‑time office, must disclose pecuniary interests (s 10F), and may be terminated by the Board for misbehaviour or incapacity with required Ministerial consultation (s 10E). The Chief Executive is excluded from Board deliberations concerning them personally (s 15A).

Industry and potential commercial partners. The Organisation is empowered to arrange research to be undertaken by any person or body (s 9AA(a)), to form or participate in companies or partnerships (s 9AA(b)), and to make available discoveries, inventions or improvements on conditions and for fees or royalties as the Chief Executive determines (s 9AA(c)). Those provisions create opportunities for private and public entities to contract with, partner with or receive licences from the Organisation. Users who access research services or facilities may be charged fees under s 9AA(e).

Donors and trustees. The Organisation may accept gifts, bequests and trust property and agree to conditions attached to them (s 9A(1)(a)-(b)), and it may act as trustee for moneys or property vested on trust (s 9A(1)(c)). Where the Organisation has agreed to conditions or holds property on trust, it must deal with those moneys or property in accordance with the conditions or trustee powers and duties (s 9A(2)). Donors who attach conditions therefore affect how the Organisation applies gifted resources.

Competitors and commercial markets. The Organisation’s statutory right to charge fees, retain and licence IP and to be exempt from taxation (s 53) places it as an actor in markets where private research providers operate. The Act permits the Organisation to invest surplus funds under the PGPA Act (s 48(2)), and to structure commercial arrangements via companies, partnerships and licences (s 9AA(b)-(c)). Those powers affect entities that compete for research contracts, licensing opportunities or facilities access.

Minister and Finance Minister. The responsible Minister may issue written directions and guidelines to the Board (s 13) and the Board must comply; the Finance Minister may direct payment timing and amounts for parliamentary appropriations payable to the Organisation (s 46(2)). The Board must consult the Minister before certain appointments and terminations of the Chief Executive (s 10B(2), s 10E(4)), and report ministerial determinations in its annual report (s 51(c)-(d)).

Advisory committee participants and employee representative organisations. The Board may establish advisory committees and appoint persons to give advice (s 24). A Consultative Council composed of nominees representing management and representatives of organisations of officers is established to consider matters affecting officers and report to the Board (s 56). Regulations will prescribe the Council’s constitution and operations (s 56(3)).

Regulators and those seeking to regulate. The Governor‑General holds power to make regulations under s 58 to effect the Act’s operation. The Remuneration Tribunal plays a role in setting pay for Board members and Chief Executive where determinations exist (ss 17, 19, 10H), so external statutory bodies affect governance outcomes.

Organisation duties and obligations. The Organisation must perform its functions in accordance with a corporate plan when one is in effect (s 36(1)). The Organisation is obliged to apply its moneys only to defined purposes (payment of organisational costs and remuneration, s 48(1)), but may invest surplus funds under the PGPA Act (s 48(2)). The Organisation must ensure compliance with any written directions or guidelines given by the Minister under s 13(1), as the Board is statutorily obliged to ensure directions and guidelines are complied with (s 13(1)).

Board duties and powers. The Board’s functions include ensuring proper and efficient performance of the Organisation’s functions, determining policy, and giving directions to the Chief Executive (s 12(1)(a)-(c)). The Board must appoint the Chief Executive (s 10B(1)); it is required to consult the Minister before making such an appointment (s 10B(2)) and before terminating the Chief Executive (s 10E(4)). The Board has the power to delegate its powers to eligible persons or committees by resolution (s 22A(1)), and to determine procedures for advisory committees (s 24(3)). The Board must keep the seal in custody and authorise its use (s 8(4)).

Chief Executive duties and powers. The Chief Executive conducts the Organisation’s affairs subject to Board policies and directions (s 10A(2)-(3)). All acts done in the name of the Organisation by or with the authority of the Chief Executive are deemed to have been done by the Organisation (s 10A(4)). The Chief Executive may determine fees, royalties and conditions for making discoveries available (s 9AA(c)), may determine bonuses for officers subject to Board approval (s 9AA(d)), and may charge fees for services and facilities (s 9AA(e)). The Chief Executive must disclose in writing all direct or indirect pecuniary interests they have in business or bodies corporate carrying on a business (s 10F(1)). The Chief Executive may delegate powers in writing to eligible persons or committees but only with the Board’s approval (s 10J(1)-(2)). Acting appointments for the Chief Executive are permitted (s 10G).

Officer rights and duties. Officers are appointed by the Chief Executive (s 32(1)) and their non‑statutory terms are determined by the Chief Executive (s 32(2)). Discoveries made by officers in the course of official duties are the Organisation’s property (s 54(1)), and officers may not apply for patents relating to their official duties without the Chief Executive’s written consent (s 54(2)). Officers are represented in the Consultative Council (s 56(1)(b)), which has the function of considering and reporting to the Board on matters affecting officers (s 56(2)).

Ministerial powers. The Minister may give written directions and guidelines to the Board and these must be complied with (s 13(1)). The Minister is also involved in appointing (through the Governor‑General) and in being consulted on certain Board actions , the Board must consult the Minister before appointing or terminating the Chief Executive (s 10B(2), s 10E(4)), and the Chairperson must convene meetings if directed by the Minister (s 15(2)). The Board’s annual report must set out ministerial determinations and directions given under the Act (s 51(c)-(d)).

Financial rights and duties. Parliament appropriates funds to the Organisation (s 46(1)), but the Finance Minister may direct timing and amounts for payment of those appropriated moneys (s 46(2)). The Organisation may charge fees for services and facilities it provides (s 9AA(e)) and may make available discoveries on terms including fees or royalties as the Chief Executive determines (s 9AA(c)). The Organisation is exempt from Commonwealth and State/Territory taxation (s 53).

Rights to enter into commercial arrangements. The Organisation may contract for work to be done by others (s 9AA(a)), join partnerships or companies (s 9AA(b)), and act as trustee in relation to gifts or other property (s 9A(1)(c)); those are explicit statutory rights.

Reporting obligations. The Organisation must include extra matters in its annual report prepared under the PGPA Act: policy statements on its scientific research policies, developments in those policies, determinations made by the Minister under s 9(1)(a)(iv) and directions or guidelines given by the Minister under s 13(1) during the reporting period (s 51(a)-(d)). The Organisation must comply with corporate planning requirements and perform functions in accordance with the corporate plan when one is in effect (s 36(1)), although non‑compliance does not invalidate acts (s 36(2)).

Remuneration and administrative duties. Remuneration of the Chairperson, Deputy Chairperson, other part‑time members and the Chief Executive is governed by Remuneration Tribunal determinations where in operation; prescribed amounts apply if no such determinations exist (ss 17, 19, 10H). The Chief Executive has leave entitlements determined by the Remuneration Tribunal and may be granted leave of absence by the Board (s 10C).

Statutory enforcement mechanisms and sanctions in the Act are largely administrative rather than criminal in form. The Act provides mechanisms for appointment termination, removal and internal control rather than standalone penal offences.

Termination and removal powers. The Board may terminate the Chief Executive’s appointment for misbehaviour or physical or mental incapacity (s 10E(1)). Specific grounds enabling termination include bankruptcy or insolvent arrangements, failure to comply with the disclosure obligation in s 10F, unauthorised absences from duty, repeated absences from Board meetings, and engaging in paid external employment without the Board’s consent (s 10E(2)(a)-(e)). The Board may also terminate for unsatisfactory performance over a significant period (s 10E(3)). The Board must consult with the Minister before terminating the Chief Executive (s 10E(4)). For part‑time members, the Governor‑General may terminate appointment for misbehaviour or incapacity (s 22(1)); specific termination grounds include bankruptcy or repeated unexcused absences (s 22(2)(a)-(b)). The Act also notes that termination may occur under s 30 of the PGPA Act for contravention of general duties of officials (notes to ss 10E and 22).

Restrictions and prohibitions with administrative consequence. Officers are required to obtain written consent of the Chief Executive before applying for patents for inventions made in the course of their official duties, and the Act prohibits such applications absent consent (s 54(2)). While the Act does not specify civil or criminal penalties for breach of s 54(2), the provision is a statutory bar likely to have employment consequences or ground for disciplinary action under organisational rules, consistent with the Consultative Council’s role to report on matters affecting officers (s 56).

Obligations to comply with Ministerial directions. The Board is required to ensure written directions and guidelines given by the Minister under s 13 are complied with (s 13(1)). Non‑compliance with Ministerial directions is therefore a statutory breach of Board duty; the Act does not prescribe a separate fine or criminal penalty, but administrative remedies include ministerial oversight (the Minister’s power to direct) and the governance remedies available under the PGPA Act, which the Act expressly incorporates by reference (note to s 8(2)).

Financial controls and reporting. The Finance Minister may give directions as to amounts and timing of payments of appropriated moneys (s 46(2)), imposing a direction‑compliance duty on the Organisation. The Organisation must include specified matters in the annual report (s 51). Failure to properly manage or report may trigger remedies or sanctions under the PGPA Act framework referenced in the Act; however, the present Act itself does not create standalone criminal penalties for reporting failures.

Procedural enforcement via appointment mechanisms. Several enforcement levers are exercised via appointments and removals: the Governor‑General, on executive advice, appoints and may terminate members (s 14A(3), s 22). The Board appoints the Chief Executive and may terminate (s 10B(1), s 10E). Those appointment and termination mechanisms operate as governance enforcement to address misbehaviour, incapacity, poor performance or conflicts of interest.

Regulatory sanctions via regulations. The Governor‑General may make regulations not inconsistent with the Act to prescribe matters necessary to give effect to the Act (s 58). The Act does not list specific penal provisions to be made by regulation; the regulatory power enables the legislature to specify further procedural, administrative or enforcement measures pursuant to statutory rule‑making, subject to consistency with the Act.

Absence of express criminal offences. The Act, as provided, does not contain express penal sanctions (fines, imprisonment) for contravention of particular operative clauses such as unauthorised patent applications, failure to follow corporate plan or misuse of moneys. Instead, the Act relies mainly on administrative controls: appointment/termination, directions, reporting duties and incorporation of PGPA governance mechanisms.

Public Governance, Performance and Accountability Act 2013 (PGPA). The Act expressly incorporates the PGPA Act as applying to the Organisation (note to s 8(2)). That cross‑reference means the Organisation is subject to the PGPA Act’s framework for corporate Commonwealth entities, including requirements for financial management, use and management of public resources, corporate planning, reporting and accountable authority duties. The Act also cross‑references specific PGPA duties: s 36 requires performance in accordance with the corporate plan, a PGPA instrument, and s 51 requires matters to be included in the annual report prepared under the PGPA Act.

Remuneration Tribunal and Remuneration Tribunal Act 1973. Remuneration for the Chairperson, Deputy Chairperson, other part‑time members and the Chief Executive is tied to determinations of the Remuneration Tribunal (ss 17, 19, 10H). Where no Tribunal determination is in operation, prescribed amounts apply. These references create an interface between the Organisation’s pay governance and Tribunal processes under the Remuneration Tribunal Act 1973.

Paris Agreement and treaty obligations. The Act defines Paris Agreement and makes explicit an internal function to contribute to giving effect to Australia’s obligations under that international instrument (s 9(1)(a)(iiia) and definition in s 7). The Act therefore creates an internal statutory mandate to account for Australia’s international climate commitments when performing scientific research functions, embedding treaty‑related policy drivers into the Organisation’s statutory functions.

Acts Interpretation Act 1901. The Act references rules on acting appointments under s 33A of the Acts Interpretation Act 1901 for the Chief Executive’s acting appointments (s 10G note). That cross‑reference ensures statutory continuity on acting appointment formalities.

Science and Industry Endowment Act 1926. The Chief Executive exercises powers under this Act and the regulations or under the Science and Industry Endowment Act 1926 (s 10A(3) cross‑reference). The exact interactions depend on provisions of the Endowment Act, but the cross‑reference signals the Organisation may be a relevant actor under that older statute and must reconcile actions between the Acts.

Taxation law. Section 53 grants the Organisation immunity from taxation under any Commonwealth, State or Territory law. That exemption interacts directly with constitutional and statutory tax regimes; the Organisation’s commercial activities will therefore be outside ordinary tax obligations that apply to private entities.

Trust and property law. Section 9A permits the Organisation to accept gifts and act as trustee, and requires compliance with conditions attached to gifts or trust property (s 9A(1)-(2)). That creates an interface with trust principles and state property law when the Organisation accepts or administers trust assets.

Corporations, partnerships and contract law. Section 9AA authorises the Organisation to form or participate in partnerships or companies and to enter contractual arrangements to have research carried out by any person or body, and to license discoveries on terms including fees or royalties. These powers require the Organisation to operate within the Corporations Act 2001, partnership law, contractual law and any regulatory regimes applying to those commercial vehicles.

Regulations and delegated law. The Governor‑General may make regulations under s 58. Those regulations, once made, will interact with the Act’s substantive provisions and with other administrative law instruments. Delegation provisions (s 10J and s 22A) require internal alignment with the Acts Interpretation Act 1901 and the PGPA Act for rule‑making on delegations and internal governance.

Employment law and public service frameworks. Staff terms are determined by the Chief Executive save where the Act prescribes otherwise (s 32(2)). Employment arrangements must align with applicable Commonwealth employment statutes, industrial instruments and the PGPA regime. The Consultative Council (s 56) provides a forum for consideration of matters affecting officers and may interact with industrial instruments and employee representation law.

Limitations and continuity. Section 36(2) states that nothing done by the Organisation is invalid solely because of failure to comply with the corporate plan. That statutory saving clause limits the potential for corporate plan non‑compliance to create legal invalidity and affects interplay with administrative law doctrines on ultra vires or procedural invalidity.

The text provided is the operative text to be read as the Act in force for the purposes of this analysis. The Act, as presented, contains provisions that reflect changes over time hydrating the statute with cross‑references and contemporary policy nodes , for example, inclusion of a function to contribute to giving effect to Australia’s obligations under the Paris Agreement (s 9(1)(a)(iiia)) and the modern corporate governance cross‑reference to the Public Governance, Performance and Accountability Act 2013 (note to s 8(2) and other references). The source document supplied does not set out an explicit amendment table, version history, or dates of amendment for individual provisions within the body of text provided here.

Given the absence of an explicit amendment schedule or marginal amendment notes in the supplied text, this note does not assert a chronology of insertions or repeals. Users seeking the historical sequence of amendments, variant text across time or the dates and instruments that amended particular subsections should consult the statutory revision history maintained by official legislative repositories (for example, the consolidated legislation database or legislative history annotations), which are not reproduced in the text provided. What the Act does show in its current form is modern governance and policy linkages: it contemplates enforcement of PGPA corporate planning and reporting mechanics (s 36 and s 51), ties remuneration to the Remuneration Tribunal (ss 17, 19, 10H), and embeds an explicit climate‑related function referencing the Paris Agreement (s 9(1)(a)(iiia) and s 7 definition). The presence of these contemporary references indicates successive legislative updates to the Act’s substantive content over time, but the source as provided does not supply the amending instruments, dates or schedules to verify the amendment pathway.

For practical purposes, queries that require knowing when a particular clause (for example s 9(iiia) or s 9AA) was inserted, or the text of a prior version, must be resolved by consulting the official consolidated legislation history or the legislative instrument that effected the change. This note does not invent amendment dates or amending instrument identifiers not contained in the supplied source.

The supplied statutory text contains no judicial decisions, case names or references to litigation. It does not cite any court interpretations or indicate how courts have construed the Act. There are no annotated cases embedded in the text provided. Consequently, the text alone supplies no litigation history for any contested provision, and no judicial authorities are named in the source material to support claims about interpretation or application in dispute.

Practitioners requiring case law , for example, on the scope of the Organisation’s commercial powers under s 9AA, the reach of the Minister’s direction power under s 13, or the characterisation of inventions as Organisation property under s 54 , will need to search judicial databases or official law reports for decisions citing the Science and Industry Research Act 1949. The Act’s cross‑references to the PGPA Act, the Remuneration Tribunal Act 1973 and other instruments mean relevant litigation may also appear under those regimes, but no such litigation is recorded in the source text provided here.

Where statutory provisions suggest likely areas of judicial attention , Board compliance with Ministerial directions (s 13), conflicts of interest and disclosure duties (s 10F), delegations (s 10J and s 22A), IP ownership (s 54) and the Organisation’s commercial activities (s 9AA) , absence of cases in the supplied text does not mean there are none. It only means the present source contains no litigation narrative. Users should obtain authoritative case law from legal research services if judicial interpretation or precedential authority is required.

Ministerial directions bind the Board. Section 13(1) permits the Minister to give written directions and guidelines to the Board with respect to the performance of functions or exercise of powers of the Board or the Organisation, and the Board must ensure compliance. The power may be exercised even where an act is subject to the approval of the Minister or another person (s 13(2)). That is a legal mechanism that can materially shape policy and operations; the Act places the obligation to comply on the Board (s 13(1)). For entities and partners contracting with the Organisation, the existence of such directions may affect predictability of policy, because the Board’s obligations may shift in response to written ministerial instructions.

Board/Chief Executive balance. The Chief Executive conducts the Organisation’s affairs subject to Board policies and directions (s 10A(2)-(3)). The Chief Executive also holds delegated powers to set fees, royalties and bonuses (s 9AA(c)-(e)), but may only delegate powers with Board approval (s 10J(1)-(2)). Those cross‑pressures mean commercial decisions (pricing, licensing) are exercisable by the Chief Executive but exist within a Board policy framework; the legislative design places internal checks (Board approval for delegations, Board oversight) alongside operational autonomy.

Corporate plan effect limited. Section 36(1) requires performance in accordance with the corporate plan when one is in effect. However, s 36(2) provides that nothing done by the Organisation is invalid solely because of failure to comply with s 36(1). That limitation reduces the legal potency of the corporate plan as a ground for invalidating actions, which may influence risk assessments by third parties relying on corporate plan compliance as a legal safeguard.

IP ownership and staff constraints. Section 54(1) makes inventions by officers in the course of official duties the property of the Organisation, and s 54(2) prohibits officers from applying for patents for such inventions without written consent of the Chief Executive. For research staff and potential recruits, this is a material constraint on personal IP rights. The Act does not prescribe an internal mechanism or timetable for consent or dispute resolution where officers seek to commercialise inventions, beyond the statutory ban on unauthorised patent applications and the Organisation’s power to pay bonuses for discoveries (s 9AA(d)). Employers and staff should be mindful that this statutory IP allocation can create incentive and retention considerations.

Tax exemption. Section 53 exempts the Organisation from taxation under Commonwealth, State and Territory law. That changes the cost calculus relative to taxed private competitors and may impact commercial pricing, profit margins and investment decisions. The Act does not impose conditions on that exemption within its text; the exemption is a statutory right that affects market parity where the Organisation competes or partners commercially.

Delegation constraints and eligibility. The Chief Executive’s delegation power is restricted by the requirement of Board approval (s 10J(2)). The Board’s delegation power is exercisable by resolution to eligible persons, defined to exclude members of the Consultative Council (s 22A(1), (4)). Delegation pathways therefore exist but are bounded by eligibility rules and internal approvals, which can slow decision cycles if used conservatively.

Accountability through annual reporting. The Act requires extra items in the Organisation’s annual report: policy statements, policy developments, ministerial determinations made under s 9(1)(a)(iv) and directions or guidelines given by the Minister under s 13(1) (s 51(a)-(d)). These reporting obligations create transparency obligations but do not, on their own, prescribe remedies for inaccuracies. Organisations and auditors must ensure these items are properly captured in PGPA corporate reporting.

Bonuses and incentives. Section 9AA(d) permits payment of bonuses to officers or persons undertaking work on behalf of the Organisation for discoveries or inventions, but such bonuses require approval by the Board and are determined by the Chief Executive. That is an internal incentive mechanism. It creates a conditional right to reward innovation, but the Act leaves the quantum, criteria and administration of bonuses to internal determination, which may create expectation‑management issues for research staff unless clearly governed in internal policy.

Use of the Organisation’s seal. Section 8(3) directs courts and judicial officers to take judicial notice of the seal’s imprint and to presume a document so sealed was duly sealed. The seal must be kept in custody as the Board directs and may only be used as authorised by the Board (s 8(4)). That evidentiary presumption simplifies proof of execution for counterparties but places a governance duty on the Board to authorise and control seal use.

Limited express penalties. The Act contains administrative removal and suspension mechanisms but no explicit statutory fines or criminal penalties for many potential breaches (for example, unauthorised patent applications are prohibited under s 54(2) but no fine is specified). Enforcement therefore tends to be managerial, ministerial or under the PGPA framework where contraventions concern public resources.

Donor conditions bind trusteeship. Section 9A(2) binds the Organisation to conditions attached to gifts, bequests or trust property and requires dealing with trust property in accordance with those conditions or trustee powers. Donors who attach conditions therefore effect enforceable constraints on how gifted resources are applied.

Establish clear corporate planning and reporting processes. When a corporate plan is in effect, the Organisation must perform functions in accordance with it (s 36(1)). Even though non‑compliance does not invalidate acts (s 36(2)), compliance is required by statute and the PGPA Act framework applies. Practical compliance steps: prepare and approve corporate plans consistent with PGPA requirements, maintain records evidencing plan adoption and revisions, and implement internal review processes to ensure operational activities align with the corporate plan. Ensure the annual report includes the extra matters required by s 51: statement of policies, developments in those policies, ministerial determinations under s 9(1)(a)(iv) and directions or guidelines given by the Minister under s 13(1).

Respect Ministerial directions and Board obligations. The Board must ensure compliance with written directions and guidelines given by the Minister (s 13(1)). To comply, establish a formal process for recording receipt of directions, assessing their scope and implementing action plans. Maintain a register of directions and ensure the annual report discloses directions given during the period (s 51(d)). The Chairperson should convene meetings when directed by the Minister (s 15(2)), so calendar and governance processes should accommodate such directives.

Governance of appointments, disclosure and termination. Follow appointment steps: part‑time members are appointed by the Governor‑General (s 14A(3)), the Chief Executive is appointed by the Board and the Board must consult the Minister prior to appointment (s 10B(1)-(2)). Ensure the Chief Executive provides written notice of all direct or indirect pecuniary interests in business or bodies corporate (s 10F(1)). Keep records of consultations with the Minister required prior to terminating or appointing the Chief Executive (s 10E(4), s 10B(2)). For part‑time members, track meeting attendance and leave records to avoid termination triggers in s 22(2)(b).

Document and control delegations. The Chief Executive may delegate powers in writing with Board approval (s 10J(1)-(2)). The Board may delegate by resolution to eligible persons (s 22A(1)). To comply, keep written delegation instruments, document the Board’s approval of delegations, define eligible persons and committees, and publish delegation registers. Ensure that delegates act subject to directions and that the delegation instruments specify limits, reporting requirements and revocation procedures as contemplated by ss 10J(4)-(5) and 22A(2)-(3).

Manage IP and inventions in line with the statute. Inventions made by officers in the course of official duties are Organisation property (s 54(1)). Officers must not apply for patents for such inventions without the Chief Executive’s written consent (s 54(2)). Implement clear IP policies: a written process for disclosure of inventions, internal assessment and decision timelines for whether to patent, licence or commercialise, templates for Chief Executive consent, and a mechanism for exercising bonus payments where appropriate (s 9AA(d)). Inform staff at recruitment and regularly by policy notice of statutory IP allocation and consent processes.

Handle gifts and trusteeship properly. The Organisation may accept gifts and act as trustee (s 9A(1)(a)-(c)) and must comply with conditions attached to gifts or trusts (s 9A(2)). To comply, establish a gifts management policy and trust administration protocols that record donor conditions, ensure legal review of proposed trust terms, and maintain trust accounting and reporting consistent with trusteeship duties.

Financial controls and adherence to appropriations. The Organisation receives moneys appropriated by Parliament (s 46(1)) and must apply moneys only to organisational costs and remuneration (s 48(1)). The Finance Minister may direct amounts and timing of payments of those appropriated moneys (s 46(2)). Integrate financial management with the PGPA Act: budget planning aligned to appropriations, systems for responding to Finance Minister directions, and investment procedures for surplus funds under PGPA s 59 as contemplated by s 48(2).

Contracting, partnerships and commercial activity. The Organisation may arrange research by others, form or participate in partnerships or companies, and make discoveries available on conditions including fees and royalties (s 9AA(a)-(c)). Ensure contracting processes are PGPA‑compliant, include appropriate conflict of interest checks, define licensing terms and royalty mechanics, and ensure internal approval workflows for fees and royalties as the Chief Executive is empowered to set them (s 9AA(c), (e)). Record Board approvals for bonus schemes and corporate participations where required (s 9AA(d)).

Remuneration and leave administration. Pay and allowances for Board members and the Chief Executive are determined by the Remuneration Tribunal where a determination exists; otherwise prescribed amounts apply (ss 17, 19, 10H). Ensure payroll, leave entitlements and Remuneration Tribunal determinations are followed; for the Chief Executive, administer recreation leave as set by the Remuneration Tribunal and Board‑approved leave of absence under s 10C.

Maintain meeting, quorum and minute procedures. The Act specifies quorums and voting rules (s 15(3)-(7)) and that the Chief Executive must not take part in Board deliberations or decisions concerning them (s 15A). To comply, keep accurate minutes, ensure quorum at meetings (four or five members depending on Board size), apply voting rules correctly including casting votes by the Chairperson, and exclude the Chief Executive from deliberations affecting them personally while disregarding them for quorum purposes (s 15A).

Record keeping for seal and documents. The seal must be kept in custody as the Board directs and used only as authorised by the Board (s 8(4)); courts shall presume a document bearing the seal was duly sealed (s 8(3)). Maintain a seal register and authorisation logs for seal use; ensure counterparties can rely on sealed documents while internal controls prevent unauthorised sealing.

Consultative and advisory bodies. Establish advisory committees and the Consultative Council according to the Act’s rules (ss 24, 56). The Board may appoint committee members and determine procedures (s 24(1)-(3)); regulations will prescribe the Consultative Council’s constitution and procedures (s 56(3)). Comply with Remuneration Tribunal determinations for advisory committee remuneration where applicable (s 24(4)).

Regulatory compliance. Stay alert to regulations made under s 58. Ensure policies and procedures remain consistent with any regulations promulgated under the Act and with PGPA obligations. Perform a legal inventory mapping Act provisions to PGPA requirements, regulations, Remuneration Tribunal determinations and any relevant external statutes (Corporations Act, taxation law, employment law, trusts law) to maintain comprehensive compliance.

Documentation and transparency for stakeholders. Given the Act’s reporting obligations (s 51) and Ministerial oversight (s 13), maintain stakeholder registers, disclosures and public‑facing reports that summarise ministerial directions, policy changes and ministerial determinations. This supports transparent compliance with statutory reporting and the expectations set by the Act.